as on November 15, 2025 at 2:29 am IST
Day's Low
Day's High
4.33%
Downside
5.20%
Upside
52 Week's Low
52 Week's High
79.83%
Downside
45.85%
Upside
Check Stoke Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.4B
EPS (TTM)
0.04
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
36.96
Industry PE ratio
-0.8126129032258065
PEG Ratio
0EBITDA
29.1M
Revenue (TTM)
205.6M
Profit Margin
19.73%
Return On Equity TTM
15.02%
Track how Stoke Therapeutics P/E has moved over time to understand its valuation trends.
Stoke Therapeutics in the last 5 years
Lowest (-33.89x)
March 31, 2021
Industry (-0.81x)
November 14, 2025
Today (36.96x)
November 14, 2025
Highest (12.98x)
September 30, 2025
Today’s Price to Earnings Ratio: 36.96x
Compare market cap, revenue, PE, and other key metrics of Stoke Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.4B | -42.05% | 36.96 | 19.73% | |
| BUY | $59.8B | 235.01% | 1414.81 | 1.36% | |
| NA | $40.9B | NA | 712.21 | 1.38% | |
| BUY | $110.2B | 92.67% | 30.58 | 31.35% | |
| BUY | $71.6B | 22.7% | 16.34 | 32.13% |
The Stoke Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Stoke Therapeutics investment value today
Current value as on today
₹1,95,712
Returns
₹95,712
(+95.71%)
Returns from Stoke Therapeutics Stock
₹90,589 (+90.59%)
Dollar Returns*
₹5,123 (+5.12%)
Based on 15 analysts
86.67%
Buy
13.33%
Hold
0.00%
Sell
Based on 15 analysts, 86.67% of analysts recommend a 'BUY' rating for Stoke Therapeutics. Average target price of $29.78
Get share price movements and forecasts by analysts on Stoke Therapeutics.
What analysts predicted
10.91%UPSIDE
Target Price
$29.78
Current Price
$26.53
Analyzed by
15 Analysts
Target
$29.78
Stoke Therapeutics target price $29.78, a slight upside of 10.91% compared to current price of $26.53. According to 15 analysts rating.
Search interest for Stoke Therapeutics Stock has increased by 64% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:64% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 06 October
Mon, 05:37 PM
-Stoke Therapeutics appoints Ian F. Smith as permanent CEO, effective October 6, 2025, emphasizing leadership stability and growth.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, STOK stock has moved up by 16.0%
Best in 1 Year
![]()
In the last 1 year, STOK has outperformed top 5 stocks with highest market-cap in its industry
Best in 3 Years
![]()
In the last 3 years, STOK has outperformed top 5 stocks with highest market-cap in its industry
Revenue Fall
![]()
Revenue is down for the last 3 quarters, 158.56M → 10.63M (in $), with an average decrease of 57.2% per quarter
Profit Down
![]()
Netprofit is down for the last 3 quarters, 112.87M → -38.34M (in $), with an average decrease of 92.1% per quarter
| Organisation | Stoke Therapeutics |
| Headquarters | 45 Wiggins Avenue, Bedford, MA, United States, 01730 |
| Industry | Health Technology |
| CEO | Mr. Ian F. Smith A.C.A., C.P.A. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Barry S. Ticho FACC, M.D., Ph.D. | Chief Medical Officer |
Ms. Isabel Aznarez Ph.D. | Co-Founder, Head of Research & Senior VP |
Mr. Jonathan Allan J.D. | Corporate Secretary & General Counsel |
Doug Snow | Director of Communications & Investor Relations |
Ms. Dawn Kalmar | Chief Communications Officer |
Ms. Sara Den Besten | Chief People Officer |
Mr. Ian F. Smith A.C.A., C.P.A. | CEO & Director |
Dr. Adrian R. Krainer Ph.D. | Co-Founder & Independent Director |
Mr. Thomas Edward Leggett | Chief Financial Officer |
Dr. Edward M. Kaye M.D., Ph.D. | Advisor & Director |
Stoke Therapeutics share price today is $26.53 as on at the close of the market. Stoke Therapeutics share today touched a day high of $27.91 and a low of $25.38.
Stoke Therapeutics share touched a 52 week high of $38.69 on and a 52 week low of $5.35 on . Stoke Therapeutics stock price today i.e. is closed at $26.53,which is 31.43% down from its 52 week high and 395.89% up from its 52 week low.
Stoke Therapeutics market capitalisation is $0.00T as on .
Indian investors can start investing in Stoke Therapeutics (STOK) shares with as little as ₹88.64 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.40 in Stoke Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Stoke Therapeutics share’s latest price of $26.53 as on November 15, 2025 at 2:29 am IST, you will get 0.3769 shares of Stoke Therapeutics. Learn more about
fractional shares .
Stoke Therapeutics stock has given -42.05% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?